4 found
Order:
  1.  47
    Cancer clinical trial participants' assessment of risk and benefit.Connie M. Ulrich, Sarah J. Ratcliffe, Gwenyth R. Wallen, Qiuping Zhou, Kathleen Knafl & Christine Grady - 2016 - AJOB Empirical Bioethics 7 (1):8-16.
  2. Hypothetical vignettes in empirical bioethics research.Connie M. Ulrich & Sarah J. Ratcliffe - 2007 - Advances in Bioethics 11:161-181.
     
    Export citation  
     
    Bookmark   7 citations  
  3.  17
    Informed Consent among Clinical Trial Participants with Different Cancer Diagnoses.Connie M. Ulrich, Sarah J. Ratcliffe, Camille J. Hochheimer, Qiuping Zhou, Liming Huang, Thomas Gordon, Kathleen Knafl, Therese Richmond, Marilyn M. Schapira, Victoria Miller, Jun J. Mao, Mary Naylor & Christine Grady - forthcoming - AJOB Empirical Bioethics.
    Importance Informed consent is essential to ethical, rigorous research and is important to recruitment and retention in cancer trials.Objective To examine cancer clinical trial (CCT) participants’ perceptions of informed consent processes and variations in perceptions by cancer type.Design and Setting and Participants Cross-sectional survey from mixed-methods study at National Cancer Institute–designated Northeast comprehensive cancer center. Open-ended and forced-choice items addressed: (1) enrollment and informed consent experiences and (2) decision-making processes, including risk-benefit assessment. Eligibility: CCT participant with gastro-intestinal or genitourinary, hematologic-lymphatic (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  4.  27
    Cancer Clinical Trial Patient-Participants’ Perceptions about Provider Communication and Dropout Intentions.Qiuping Zhou, Sarah J. Ratcliffe, Christine Grady, Tianhao Wang, Jun J. Mao & Connie M. Ulrich - 2019 - AJOB Empirical Bioethics 10 (3):190-200.
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark